Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules.
Nucleoside analogues are widely used in the treatment of various viral infections. However, the poor in vivo conversion of the nucleoside analogues like azidothymidine (AZT) into their active triphosphate nucleotide counterpart limits their pharmacological efficacy. This could be overcome by the direct administration of azidothymidine triphosphate (AZT-TP), but it requires an appropriate drug delivery approach. Besides nucleoside analogues, nucleotide analogues like cidofovir (CDV) are also used in the treatment of viral infections. CDV has raised recent interest because of its promising activity against smallpox, but its use is limited by its poor bioavailability and nephrotoxicity. Here again, a proper drug delivery system should address these issues. In this study, we investigated the encapsulation of the nucleotide analogues AZT-TP and CDV into poly(iso-butylcyanoacrylate) aqueous core nanocapsules, known to efficiently entrap oligonucleotides. We show here that the encapsulation of these mono-nucleotides is less efficient than with oligonucleotides and that a rapid release of AZT-TP from the nanocapsules occurred in vitro. This highlights the importance of the molecular weight of the entrapped molecules which, if they are too small, are diffusing through the thin polymer membrane of the nanocapsules. On the other hand, a good protection of the encapsulated AZT-TP was observed.
Hillaireau
H
H
UMR CNRS 8612, Laboratoire de Physico-Chimie, Pharmacotechnie, Biopharmacie, Faculté de Pharmacie, Université Paris-Sud, 5 rue J.B. Clément, 92296 Châtenay-Malabry, France.
Le Doan
T
T
Besnard
M
M
Chacun
H
H
Janin
J
J
Couvreur
P
P
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000737:chemistry; D002214:Capsules; D002851:Chromatography, High Pressure Liquid; D000077404:Cidofovir; D003487:Cyanoacrylates; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry; D004339:Drug Compounding; D004659:Enbucrilate; D005612:Freeze Drying; D008855:Microscopy, Electron, Scanning; D063065:Organophosphonates / Q000008:administration & dosage* / Q000737:chemistry; D010316:Particle Size; D011108:Polymers; D015215:Zidovudine / Q000008:administration & dosage* / Q000737:chemistry
D019380:Anti-HIV Agents; D002214:Capsules; D003487:Cyanoacrylates; D063065:Organophosphonates; D011108:Polymers; D015215:Zidovudine; D003596:Cytosine; D004659:Enbucrilate; D000077404:Cidofovir